Adaptive Biotechnologies (ADPT) Insider Trading & Ownership $10.63 +0.17 (+1.63%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$10.63 0.00 (0.00%) As of 04:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Adaptive Biotechnologies (NASDAQ:ADPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$6.56M Get ADPT Insider Trade Alerts Want to know when executives and insiders are buying or selling Adaptive Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADPT Insider Buying and Selling by Quarter Adaptive Biotechnologies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/16/2025Kyle PiskelCFOSell1,929$8.89$17,148.81 5/1/2025Harlan S RobinsInsiderSell68,412$7.35$502,828.20 3/24/2025Harlan S RobinsInsiderSell1,698$9.00$15,282.00 3/12/2025Robert HershbergDirectorSell53,000$7.59$402,270.00 3/10/2025Peter M NeupertDirectorSell10,000$7.05$70,500.00 3/6/2025Michelle Renee GriffinDirectorSell15,664$7.94$124,372.16 3/5/2025Chad M RobinsCEOSell117,351$6.98$819,109.98 3/5/2025Francis LoInsiderSell20,875$6.99$145,916.25 3/5/2025Julie RubinsteinCOOSell59,505$6.98$415,344.90 3/5/2025Kyle PiskelCFOSell10,320$6.98$72,033.60 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/20/2025Chad M RobinsCEOSell99,107$8.44$836,463.08 2/18/2025Chad M RobinsCEOSell211,160$8.50$1,794,860.00 2/14/2025Chad M RobinsCEOSell158,921$8.46$1,344,471.66 11/18/2024Kyle PiskelCFOSell248$4.98$1,235.04 (Data available from 1/1/2013 forward) ADPT Insider Trading Activity - Frequently Asked Questions Who is on Adaptive Biotechnologies's Insider Roster? The list of insiders at Adaptive Biotechnologies includes Chad M Robins, Francis Lo, Harlan S Robins, Julie Rubinstein, Kyle Piskel, Michelle Renee Griffin, Nitin Sood, Peter M Neupert, R Mark Adams, Robert Hershberg, Stacy L Taylor, and Tycho Peterson. Learn more on insiders at ADPT. What percentage of Adaptive Biotechnologies stock is owned by insiders? 6.40% of Adaptive Biotechnologies stock is owned by insiders. Learn more on ADPT's insider holdings. Which Adaptive Biotechnologies insiders have been selling company stock? The following insiders have sold ADPT shares in the last 24 months: Chad M Robins ($4,961,853.11), Francis Lo ($145,916.25), Harlan S Robins ($518,110.20), Julie Rubinstein ($550,917.80), Kyle Piskel ($117,990.73), Michelle Renee Griffin ($124,372.16), Nitin Sood ($38,320.56), Peter M Neupert ($70,500.00), Robert Hershberg ($402,270.00), Stacy L Taylor ($45,896.83), and Tycho Peterson ($1,748,851.18). How much insider selling is happening at Adaptive Biotechnologies? Insiders have sold a total of 1,163,369 Adaptive Biotechnologies shares in the last 24 months for a total of $8,724,998.82 sold. Adaptive Biotechnologies Key ExecutivesMr. Chad M. Robins M.B.A. (Age 49)Co-Founder, CEO & Chairman Compensation: $1M4 recent tradesMs. Julie Rubinstein (Age 52)President & COO Compensation: $721.04k1 recent tradesDr. Harlan S. Robins Ph.D. (Age 51)Co-Founder & Chief Scientific Officer Compensation: $711.09kDr. Sharon Benzeno Ph.D. (Age 50)Chief Commercial Officer of Immune Medicine Compensation: $630.72kMr. Christopher Carlson Ph.D.FounderMr. Kyle Piskel (Age 40)VP, CFO & Principal Accounting Officer Compensation: $375.9k2 recent tradesKarina CalzadillaVice President of Investor RelationsMs. Stacy L. Taylor (Age 64)Senior VP, General Counsel & Corporate Secretary Mr. Francis T. Lo (Age 43)Chief People Officer 1 recent tradesMs. Susan Bobulsky (Age 43)Chief Commercial Officer of MRD More Insider Trading Tools from MarketBeat Related Companies Grifols Insider Trading TG Therapeutics Insider Trading Nuvalent Insider Trading Lantheus Insider Trading Axsome Therapeutics Insider Trading ADMA Biologics Insider Trading Vaxcyte Insider Trading Merus Insider Trading Rhythm Pharmaceuticals Insider Trading Akero Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite Disparity This page (NASDAQ:ADPT) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
